Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Waal

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
BMJ Open|October 18, 2019
Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocolMohammad Bagher Saberi Zafarghandi, Sahar Eshrati, Meroe Vameghi, et al.
Journal of Forensic and Legal Medicine|October 7, 2015
Characteristics of methadone-related fatalities in NorwayJean-Paul Bernard, Hassan Z Khiabani, Thor Hilberg, et al.
European Addiction Research|November 18, 2021
Indicators of Drug-Related Community Impacts of Open Drug Scenes: A Scoping ReviewMohammad Bagher Saberi Zafarghandi, Sahar Eshrati, Vahid Rashedi, et al.
Scandinavian Journal of Public Health|January 11, 2013
Diversity in causes and characteristics of drug-induced deaths in an urban settingLinn Gjersing, Kristine V Jonassen, Stian Biong, et al.
European Addiction Research|May 14, 2015
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009Gabrielle K Welle-Strand, Svetlana Skurtveit, Lars Tanum, et al.
Addiction (Abingdon, England)|August 2, 2020
Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrationsAnne Berit Bech, Thomas Clausen, Helge Waal, et al.
European Addiction Research|August 23, 2022
Mortality, Causes of Death, and Predictors of Death among Patients On and Off Opioid Agonist Treatment: Results from a 19-Year Cohort StudyIvar Skeie, Thomas Clausen, Arne Jan Hjemsæter, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 30, 2009
Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trialNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Drug and Alcohol Dependence|June 24, 2010
Retention in naltrexone implant treatment for opioid dependenceNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Addiction (Abingdon, England)|August 17, 2010
Challenges to antagonist blockade during sustained-release naltrexone treatmentNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
BMJ Open|October 18, 2019
Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocolMohammad Bagher Saberi Zafarghandi, Sahar Eshrati, Meroe Vameghi, et al.
Journal of Forensic and Legal Medicine|October 7, 2015
Characteristics of methadone-related fatalities in NorwayJean-Paul Bernard, Hassan Z Khiabani, Thor Hilberg, et al.
European Addiction Research|November 18, 2021
Indicators of Drug-Related Community Impacts of Open Drug Scenes: A Scoping ReviewMohammad Bagher Saberi Zafarghandi, Sahar Eshrati, Vahid Rashedi, et al.
Scandinavian Journal of Public Health|January 11, 2013
Diversity in causes and characteristics of drug-induced deaths in an urban settingLinn Gjersing, Kristine V Jonassen, Stian Biong, et al.
European Addiction Research|May 14, 2015
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009Gabrielle K Welle-Strand, Svetlana Skurtveit, Lars Tanum, et al.
Addiction (Abingdon, England)|August 2, 2020
Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrationsAnne Berit Bech, Thomas Clausen, Helge Waal, et al.
European Addiction Research|August 23, 2022
Mortality, Causes of Death, and Predictors of Death among Patients On and Off Opioid Agonist Treatment: Results from a 19-Year Cohort StudyIvar Skeie, Thomas Clausen, Arne Jan Hjemsæter, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 30, 2009
Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trialNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Drug and Alcohol Dependence|June 24, 2010
Retention in naltrexone implant treatment for opioid dependenceNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Addiction (Abingdon, England)|August 17, 2010
Challenges to antagonist blockade during sustained-release naltrexone treatmentNikolaj Kunøe, Philipp Lobmaier, John Kåre Vederhus, et al.
Pageof 9